Literature DB >> 4024879

Comparison of cellular levels of steroid receptors in uterine leiomyoma and myometrium.

T Tamaya, J Fujimoto, H Okada.   

Abstract

To support the estrogen hypothesis in the pathogenesis of leiomyoma, total cellular estrogen receptor (ER) levels (the sum of levels in cytosol and nuclear KCl-extractable and nuclear non-KCl-extractable fractions) were assayed and compared with levels of progestin (PR) and androgen (AR) receptors in the leiomyoma and the corresponding myometrium. The ratios of ER to PR or AR levels were higher (with statistical significance) in leiomyoma than in the corresponding normal myometrium, both in terms of total cellular levels in each individual case and nuclear levels. It appears that estrogen sensitivity is higher in the leiomyoma than in the corresponding myometrium, due to the relative increase in ER.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4024879     DOI: 10.3109/00016348509155136

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  14 in total

1.  Immunoexpression of Steroid Hormone Receptors and Proliferation Markers in Uterine Leiomyoma and Normal Myometrial Tissues from the Miniature Pig, Sus scrofa.

Authors:  Kristie Mozzachio; Alicia B Moore; Grace E Kissling; Darlene Dixon
Journal:  Toxicol Pathol       Date:  2015-12-20       Impact factor: 1.902

Review 2.  The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy.

Authors:  Reshef Tal; James H Segars
Journal:  Hum Reprod Update       Date:  2013-09-29       Impact factor: 15.610

3.  Androgen receptors in normal and pathological thyroids.

Authors:  M Marugo; G Torre; D Bernasconi; L Fazzuoli; S Cassulo; G Giordano
Journal:  J Endocrinol Invest       Date:  1991-01       Impact factor: 4.256

Review 4.  Leiomyomata uteri: hormonal and molecular determinants of growth.

Authors:  Richard Enrique Blake
Journal:  J Natl Med Assoc       Date:  2007-10       Impact factor: 1.798

5.  Immunohistochemical analysis of oestrogen receptors, progesterone receptors and Ki-67 in leiomyoma and myometrium during the menstrual cycle and pregnancy.

Authors:  K Kawaguchi; S Fujii; I Konishi; T Iwai; Y Nanbu; H Nonogaki; Y Ishikawa; T Mori
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

Review 6.  Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.

Authors:  Molly B Moravek; Ping Yin; Masanori Ono; John S Coon; Matthew T Dyson; Antonia Navarro; Erica E Marsh; Debabrata Chakravarti; J Julie Kim; Jian-Jun Wei; Serdar E Bulun
Journal:  Hum Reprod Update       Date:  2014-09-08       Impact factor: 15.610

7.  Shrinkage of uterine fibroids by preoperative LHRH analogue injection.

Authors:  H R McClelland; A J Quinn
Journal:  Ulster Med J       Date:  1992-04

8.  Comparison of estrogen receptor-α, progesterone receptor and calponin expression in gonadotrophin-releasing hormone agonist-sensitive and -resistant uterine fibroids.

Authors:  Eun Hee Kim; Joo Young Kim; Yoon Hee Lee; Gun Oh Chong; Ji Young Park; Dae Gy Hong
Journal:  Obstet Gynecol Sci       Date:  2014-03-15

Review 9.  Etiology and pathogenesis of uterine leiomyomas: a review.

Authors:  Gordon P Flake; Janet Andersen; Darlene Dixon
Journal:  Environ Health Perspect       Date:  2003-06       Impact factor: 9.031

Review 10.  Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids.

Authors:  Nicoletta Biglia; Silvestro Carinelli; Antonio Maiorana; Marta D'Alonzo; Giuseppe Lo Monte; Roberto Marci
Journal:  Drug Des Devel Ther       Date:  2014-02-20       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.